Inclusion Criteria:  Symptoms of overactive bladder with urgency urinary incontinence, with or without nocturia/nocturnal enuresis Symptoms of mixed urinary incontinence if urgency incontinence is the predominant complaint Post-void residual <100ml English speaking Access to a smartphone Normal urinalysis without evidence of UTI, gross or microscopic hematuria Greater than 6 months since receiving intradetrusor injection of botulinum toxin Not currently undergoing sacral neuromodulation therapy Not currently receiving pharmacotherapy for overactive bladder  Exclusion Criteria:  Less than 40 years of age Mixed incontinence with predominant stress urinary incontinence symptoms Diagnosis of chronic pelvic pain symptomatic pelvic organ prolapse symptoms of dysuria Diagnosis of interstitial cystitis/painful bladder syndrome Reported >2 UTI in 6 months or >3 in 12 months Do not have access to a smartphone Non-English speaking Diagnosis of neurogenic bladder Gross or microscopic hematuria Has diagnosis of dementia, cognitive impairment or other neurologic condition which impairs decision making Current Pharmacotherapy or neuromodulation therapy Less than 6 months since intradetrusor botulinum toxin injection Has decreased mobility or ambulation Has post-void residual >100 mL Has BMI > 40 kg/m^2 Inability to voluntarily contract the pelvic floor muscles (a 0/5 in strength). Has >4/10 pain with palpation of levator ani, coccygeus, pyriformis, obturator internus or perineal body